A murine leukemia virus (MuLV) long terminal repeat derived from rhesus macaques in the context of a lentivirus vector and MuLV gag sequence results in high-level gene expression in human T lymphocytes

Journal of Virology

Volumn 74, Issue 8, 2000, Pages 3668-3681

  Kung, Sam K P ^a   An, Dong Sung ^a   Chen, Irvin S Y ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN; GREEN FLUORESCENT PROTEIN; PHOSPHOGLYCERATE KINASE; VIRUS PROTEIN; VIRUS VECTOR;

ARTICLE; CYTOMEGALOVIRUS; GENE EXPRESSION; GENE THERAPY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; LONG TERMINAL REPEAT; MURINE LEUKEMIA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; RETROVIRUS; RHESUS MONKEY; T LYMPHOCYTE;

ANIMALS; CELL LINE; CELLS, CULTURED; FLOW CYTOMETRY; GENE EXPRESSION; GENE PRODUCTS, GAG; GENES, GAG; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; LENTIVIRUS; LEUKEMIA VIRUS, MURINE; LUMINESCENT PROTEINS; LYMPHOCYTE ACTIVATION; MACACA MULATTA; MOLONEY MURINE LEUKEMIA VIRUS; PROMOTER REGIONS (GENETICS); T-LYMPHOCYTES; TERMINAL REPEAT SEQUENCES;

EID: 0034071645     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.8.3668-3681.2000     Document Type: Article

References (31)

1. Akkina, R. K., J. D. Rosenblatt, A. G. Campbell, I. S. Chen, and J. A. Zack. 1994. Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse. Blood 84:1393-1398.
2. + cells. J. Virol. 74:1286-1295.
3. An, D. S., Y. Koyanagi, J. Q. Zhao, R. Akkina, G. Bristol, N. Yamamoto, J. A. Zack, and I. S. Chen. 1997. High-efficiency transduction of human lymphoid progenitor cells and expression in differentiated T cells. J. Virol. 71:1397-1404.
4. An, D. S., K. Morizono, Q. X. Li, S. H. Mao, S. Lu, and I. S. Chen. 1999. An inducible human immunodeficiency virus type 1 (HIV-1) vector which effectively suppresses HIV-1 replication. J. Virol. 73:7671-7677.
5. Bender, M. A., T. D. Palmer, R. E. Gelinas, and A. D. Miller. 1987. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J. Virol. 61:1639-1646.
6. Blomer, U., L. Naldini, T. Kafri, D. Trono, I. M. Verma, and F. H. Gage. 1997. Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71:6641-6649.
7. Bonyhadi, M. L., K. Moss, A. Voytovich, J. Auten, C. Kalfoglou, I. Plavec, S. Forestell, L. Su, E. Bohnlein, and H. Kaneshima. 1997. RevM10-expressing T cells derived in vivo from transduced human hematopoietic stem-progenitor cells inhibit human immunodeficiency virus replication. J. Virol. 71: 4707-4716.
8. Case, S. S., M. A. Price, C. T. Jordan, X. J. Yu, L. Wang, G. Bauer, D. L. Haas, D. Xu, R. Stripecke, L. Naldini, D. B. Kohn, and G. M. Crooks. 1999. Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc. Natl. Acad. Sci. USA 96:2988-2993.
9. Donahue, R. E., S. W. Kessler, D. Badine, K. McDonagh, C. Dunbar, S. Goodman, B. Agricola, E. Byrne, M. Raffeld, and R. Moen. 1992. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J. Exp. Med. 176:1125-1135.
10. Greenberg, P. D., and S. R. Riddell. 1999. Deficient cellular immunity - finding and fixing the defects. Science 285:546-551.
11. Hershfield, M. S. 1998. Adenosine deaminase deficiency: clinical expression, molecular basis, and therapy. Semin. Hematol. 35:291-298.
12. Kafri, T., U. Blomer, D. A. Peterson, F. H. Gage, and I. M. Verma. 1997. Sustained expression of genes delivered directly into liver and muscle by lentiviral vectors. Nat. Genet. 17:314-317.
13. Kim, V. N., K. Mitrophanous, S. M. Kingsman, and A. J. Kingsman. 1998. Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J. Virol. 72:811-816.
14. King, J. A., J. M. Bridger, F. Gounari, P. Lichter, T. F. Schulz, V. Schirrmacher, and K. Khazaie. 1998. The extended packaging sequence of MoMLV contains a constitutive mRNA nuclear export function. FEBS Lett. 434:367-371.
15. Landau, N. R., and D. R. Littman. 1992. Packaging system for rapid production of murine leukemia virus vectors with variable tropism. J. Virol. 66: 5110-5113.
16. Meyaard, L., H. Schuitemaker, and F. Miedema. 1993. T-cell dysfunction in HIV infection: anergy due to defective antigen-presenting cell function? Immunol. Today 14:161-164.
17. Miller, A. D., and G. J. Rosman. 1989. Improved retroviral vectors for gene transfer and expression. BioTechniques 7:980-986, 989.
18. Miyoshi, H., M. Takahashi, F. H. Gage, and I. M. Verma. 1997. Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Proc. Natl. Acad. Sci. USA 94:10319-10323.
19. Miyoshi, H., U. Blomer, M. Takahashi, F. H. Gage, and I. M. Verma. 1998. Development of a self-inactivating lentivirus vector. J. Virol. 72:8150-8157.
20. Miyoshi, H., K. A. Smith, D. E. Mosier, I. M. Verma, and B. E. Torbett. 1999. Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors. Science 283:682-686.
21. Mochizuki, H., J. P. Schwartz, K. Tanaka, R. O. Bradj, and J. Reiser. 1998. High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J. Virol. 72:8873-8883.
22. Naldini, L., U. Blomer, F. H. Gage, D. Trono, and I. M. Verma. 1996. Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93:11382-11388.
23. Naldini, L., U. Blomer, P. Gallay, D. Ory, R. Mulligan, F. H. Gage, I. M. Verma, and D. Trono. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
24. Purcell, D. F. J., C. M. Broscius, E. F. Vanin, C. E. Buckler, A. W. Nienhuis, and M. A. Martin. 1996. An array of murine leukemia virus-related elements is transmitted and expressed in a primate recipient of retroviral gene transfer. J. Virol. 70:887-897.
25. Roe, T., T. C. Reynolds, G. Yu, and P. O. Brown. 1993. Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12:2099-2108.
26. Russell, S. M., N. Tayebi, H. Nakajima, M. C. Riedy, J. L. Roberts, M. J. Aman, T. S. Migone, M. Noguchi, M. L. Markert, and R. H. Buckley. 1995. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development. Science 270:797-800.
27. Sutton, R. E., H. T. Wu, R. Rigg, E. Bohnlein, and P. O. Brown. 1998 Human immunodeficiency virus type 1 vectors efficiently transduce human hematopoietic stem cells. J. Virol. 72:5781-5788.
28. Tsichlis, P. N., and P. A. Lazo. 1991. Virus-host interactions and the pathogenesis of murine and human oncogenic retroviruses. Curr. Top. Microbiol. Immunol. 171:95-171.
29. Vanin, E. F., M. Kaloss, C. Broscius, and A. W. Nienhuis. 1994. Characterization of replication-competent retroviruses from nonhuman primates with virus-induced T-cell lymphomas and observations regarding the mechanism of oncogenesis. J. Virol. 68:4241-12511.
30. Zufferey, R., D. Nagy, R. J. Mandel, L. Naldini, and D. Trono. 1997. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15:871-875.
31. Zufferey, R., T. Dull, R. J. Mandel, A. Bukovsky, D. Quiruz, L. Naldini, and D. Trono. 1998. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72:9873-9880.